Acadian Asset Management LLC Hookipa Pharma Inc. Transaction History

Acadian Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$0.59 - $1.04 $64,217 - $113,197	108,844 Added 12.34%	991,106 $586,000
Q1 2024 May 10, 2024	BUY	$0.61 - $0.83 $248,594 - $338,251	407,532 Added 85.85%	882,262 $627,000
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.86 $19,478 - $39,884	46,377 Added 10.83%	474,730 $383,000
Q2 2023 Aug 07, 2023	SELL	$0.71 - $1.97 $180,337 - $500,372	-253,996 Reduced 37.22%	428,353 $375,000
Q1 2023 May 11, 2023	BUY	$0.72 - $1.03 $27,906 - $39,921	38,759 Added 6.02%	682,349 $500,000
Q4 2022 Feb 14, 2023	BUY	$0.73 - $14.6 $416,251 - $8.33 Million	570,208 Added 777.04%	643,590 $520,000
Q3 2022 Nov 14, 2022	BUY	$1.27 - $15.0 $93,195 - $1.1 Million	73,382 New	73,382 $97,000
Q2 2022 Aug 09, 2022	SELL	$1.33 - $2.31 $29,898 - $51,928	-22,480 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.26 - $2.52 $289,517 - $579,035	-229,776 Reduced 91.09%	22,480 $51,000
Q4 2021 Feb 10, 2022	BUY	$2.33 - $5.94 $398,474 - $1.02 Million	171,019 Added 210.52%	252,256 $587,000
Q3 2021 Nov 12, 2021	BUY	$5.89 - $9.35 $131,776 - $209,187	22,373 Added 38.01%	81,237 $477,000
Q2 2021 Aug 11, 2021	BUY	$9.16 - $19.51 $539,194 - $1.15 Million	58,864 New	58,864 $539,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.